Coeptis Therapeutics Holdings, Inc. (COEP) - Dilution Analysis

8-K filing: Z Squared Inc. entered into a Binding Letter of Intent to acquire 100% of the issued and outstanding membership interests of Skycore Digital LLC by issuing Series B Convertible Preferred Stock. ($22.0M proceeds)

10-Q filing | 4.8M shares outstanding

10-Q filing | 3.5M shares outstanding

S-1/A filing: This S-1/A filing relates to the resale of common stock by selling stockholders and the potential sale of common stock to Yorkville under the Standby Equity Purchase Agreement.

10-K filing | 3.4M shares outstanding

S-1/A filing: This S-1/A filing relates to the resale of common stock by selling stockholders and the potential issuance of shares to Yorkville under a Standby Equity Purchase Agreement.

S-1 filing: This S-1 filing describes the resale of up to 3,919,349 shares of common stock by selling stockholders, including shares issued or to be issued to YA II PN, LTD. pursuant to a Standby Equity Purchase Agreement, and includes a potential offering of common stock to Yorkville for up to $20,000,000.

8-K filing: Stock split 1-for-20 | Outstanding: 39,806,505 → 1,990,325

10-Q filing | 39.8M shares outstanding

8-K filing: The Company entered into a Standby Equity Purchase Agreement with YA II PN, LTD, a Cayman Islands exempt limited partnership, to sell up to $20.0 million of Common Stock, and also entered into a Registration Rights Agreement with Yorkville to register the resale of shares of Common Stock issued to Yorkville pursuant to the SEPA.

10-Q filing | 37.6M shares outstanding

8-K filing: Coeptis Therapeutics Holdings, Inc. sold 4,300 shares of Series A Preferred Stock at $1,000 per share, raising $4.3 million in a financing led by CJC Investment Trust. ($4.3M proceeds)

10-Q filing | 35.5M shares outstanding

10-K filing | 36.1M shares outstanding

S-1 filing: This S-1 filing describes the offering of up to 12,080,000 shares of common stock by selling stockholders, as well as shares issuable upon exercise of various warrants. The company will not receive any proceeds from the sale of shares by the selling stockholders, but will receive proceeds from warrant exercises.

10-Q filing | 34.1M shares outstanding

8-K filing: Coeptis Therapeutics Holdings, Inc. completed a private placement involving the issuance and sale of 777,000 shares of common stock, pre-funded warrants to purchase 1,223,000 shares, Series A warrants to purchase 2,000,000 shares, and Series B warrants to purchase 2,000,000 shares, for net proceeds of approximately $1.73 million, which will be used for product development and general corporate purposes.

8-K filing: The company agreed to issue 2,400,000 shares of common stock to Biofin Ventures, LLC and 600,000 shares of common stock to AG Bio Life Capital I LP, in exchange for cash and promissory notes. ($3.0M proceeds)

8-K filing: Coeptis Therapeutics Holdings, Inc. entered into an exclusive licensing arrangement with Deverra Therapeutics Inc., purchasing assets and sublicensing rights, and in consideration, the Company paid Deverra approximately $570,000 in cash and issued 4,000,000 shares of the Company's common stock.

10-Q filing | 25.1M shares outstanding

8-K filing: Coeptis Therapeutics Holdings, Inc. closed a public offering on June 16, 2023, issuing 2,150,000 shares of common stock and 1,350,000 pre-funded warrants, along with Series A and Series B warrants, for gross proceeds of approximately $3.5 million before deducting expenses. ($14.0M proceeds)

S-1/A filing: Coeptis Therapeutics Holdings, Inc. is offering 2,631,579 shares of common stock and/or pre-funded warrants and accompanying Series A and B Warrants at an assumed price of $1.52 per share for general corporate purposes.

S-1/A filing: The filing is an S-1/A amendment related to a securities offering, detailing general expenses associated with the offering, including filing fees, legal counsel fees, and underwriter expenses.

S-1/A filing: Coeptis Therapeutics Holdings, Inc. is offering 4,081,633 shares of common stock and accompanying warrants. They are also offering pre-funded warrants to purchase shares of common stock.

10-Q filing | 20.1M shares outstanding

S-1/A filing: This is an S-1/A filing for Coeptis Therapeutics Holdings, Inc., detailing an offering of units, each consisting of one share of common stock and a warrant to purchase one-half of one share of common stock, at an assumed public offering price of $1.34 per unit. The company intends to use the net proceeds from the sale of Units in this Offering for general corporate purposes, including working capital and for continued investments in our product development efforts.

10-K filing | 20.4M shares outstanding

S-1 filing: This S-1 filing outlines Coeptis Therapeutics Holdings, Inc.'s plans for a unit offering, each unit containing one share of common stock and a warrant to purchase one-half of one share of common stock, with the proceeds intended for general corporate purposes and product development investments.

10-Q filing | 5.1M shares outstanding

10-Q filing | 5.1M shares outstanding

10-Q filing | 9.4M shares outstanding

10-K filing | 9.4M shares outstanding

10-Q filing | 9.4M shares outstanding

10-Q filing | 3.3M shares outstanding

10-Q filing | 9.4M shares outstanding

10-K filing | 9.4M shares outstanding

8-K filing: Bull Horn Holdings Corp. consummated its initial public offering of 7,500,000 units at $10.00 per unit, generating gross proceeds of $75,000,000, and the underwriters did not exercise their over-allotment option. Bull Horn Holdings Sponsor LLC returned 281,250 ordinary shares to the company for no consideration, which were then cancelled. ($75.0M proceeds)

10-Q filing | 9.7M shares outstanding

8-K filing: Bull Horn Holdings Corp. consummated its initial public offering of 7,500,000 units at $10.00 per unit, generating gross proceeds of $75,000,000, and completed the private sale of 3,750,000 warrants to the Sponsor and the Underwriters at $1.00 per warrant, generating gross proceeds of $3,750,000. ($78.75M proceeds)

POS AM filing: Bull Horn Holdings Corp. is filing a POS AM to update certain terms of the offering including: (i) an increase in the potential number of anchor investors, (ii) an increase in the size of the private placement and (iii) an increase in the amount held in the Registrant's trust account.

S-1/A filing: This is an S-1/A filing for an initial public offering of units of Bull Horn Holdings Corp., a blank check company, with each unit consisting of one ordinary share and one warrant.

S-1/A filing: This is an S-1/A filing for an initial public offering of units by Bull Horn Holdings Corp., a blank check company. They are offering 7,500,000 units at $10.00 per unit, with each unit consisting of one ordinary share and one redeemable warrant.

S-1/A filing: Bull Horn Holdings Corp. is offering 7,500,000 units at an offering price of $10.00 per unit in an initial public offering.

S-1/A filing: Bull Horn Holdings Corp. is offering 7,500,000 units at an offering price of $10.00 per unit in an initial public offering.

S-1 filing: Bull Horn Holdings Corp. is offering 7,500,000 units at $10.00 per unit in an initial public offering. Each unit consists of one ordinary share and one warrant. They are also offering private placement warrants to the sponsor and underwriter.